Featured Research

from universities, journals, and other organizations

Reengineering salmonella-based vaccines to deliver protective immunity

Date:
February 18, 2014
Source:
Arizona State University
Summary:
An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines or RASVs can be perfected, they hold the promise of safe, lost-cost, orally administered defenses against viral, bacterial, fungal and parasitic infections. Researchers propose an improved method of screening salmonella vaccines in small animal studies and enhancing their effectiveness in humans.

Color-enhanced scanning electron micrograph showing Salmonella typhimurium (red) invading cultured human cells.
Credit: Rocky Mountain Laboratories, NIAID, NIH

An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines or RASVs can be perfected, they hold the promise of safe, lost-cost, orally administered defenses against viral, bacterial, fungal and parasitic infections.

In a new study, lead author Karen Brenneman and her colleagues at the Biodesign Institute at Arizona State University, propose an improved method of screening salmonella vaccines in small animal studies and enhancing their effectiveness in humans.

The new research demonstrates a system for improving the ability of salmonella vaccine strains to survive the hostile environment of the stomach, where high acid concentrations are typically lethal for invasive bacteria. The data show a 10-fold improvement in salmonella survivability in a mouse model, modified to mimic stomach acid conditions in humans.

The research team -- which included Crystal Willingham, Jacquelyn A. Kilbourne, Kenneth Roland and Roy Curtiss III (director of Biodesign's Center for Infectious Diseases and Vaccinology) -- recently reported their results in the journal PLOS ONE.

"Over the years, the mouse model has taught us a lot about how Salmonella interacts with mammalian hosts. However, it turns out that the mouse model fails to provide relevant information on how Salmonella is able to deal with the extremely low pH of the human stomach," says Roland, corresponding author of the new study.

An RASV vaccine uses salmonella -- causative agent of gastrointestinal disorders, including common food poisoning. Researchers in the Curtiss lab have been modifying salmonella by removing virulence factors that cause illness and outfitting the bacterium with key antigens associated with the vaccine disease target.

Salmonella-based vaccines are capable of powerfully stimulating mucosal, humoral and cellular immunity against invasive pathogens, but to be effective, the vaccine cargo ships -- the salmonella -- must survive hostile conditions of the stomach.

While RASV results in mice have been encouraging, human trials have proven less favorable. The authors speculate that the high acid (low pH) conditions of human stomachs compared with mice, may be partly responsible for the discrepancy.

Many types of salmonella exist and the form affecting humans -- Salmonella enterica serotype Typhi -- is species specific. To test RASV vaccines in vivo prior to human clinical trials requires the use of Salmonella Typhimurium, a closely related strain affecting mice and producing an illness similar to human typhoid.

One critical area in which mice differ from humans however, is in the acidity of their stomachs. For humans, the pH level in an empty stomach is between 1.0 and 3.0, whereas for mice, it is around 4.0.

"Finding a way to temporarily lower the stomach pH of a mouse sets the stage for further research into designing more effective oral vaccines such as RASVs and will provide new insights into how wild-type pathogenic bacteria survive this barrier.Our paper also demonstrates the utility of our previously described, novel acid-resistance systems to increase survival of RASVs in vivo at low pH,"Roland says.

In the new study, high acid conditions in the mouse stomach were transiently induced through the injection of histamine. The histamine mouse model was capable of distinguishing Salmonella strains showing acid sensitivity or acid resistance, previously identified under laboratory conditions. The observed results in histamine mice were shown to closely correlate with in vitro acid resistance or sensitivity.

Low gastric pH is common to many host species, including humans, and acts in part as a defense mechanism to kill the majority of ingested microbes. The microbes however have actively developed strategies to attempt to survive such conditions, in a kind of evolutionary arms race.

Some microbes fare better than others under low pH, however. S. Typhi -- the salmonella strain used for RASV's -- is normally rather intolerant of low pH conditions, compared with the S. Typhimurium strains tested in mice.

A further factor of critical importance is the difference in gastric biology between mice in humans. Prior to RASV vaccine administration, both mice and humans are usually fasted in order to empty the upper part of the gastrointestinal tract. In mice, this has the effect of raising pH from around 3.0 to 4.0. In humans however, fasting pH is lowered, falling below 2.0 As the authors note, the mouse stomach after fasting poses only a mild challenge to the RASV invasive bacteria, whereas in the human stomach, conditions are hostile enough to kill most vaccine cells, undermining effectiveness.

Bacterial cells used for RASVs are generally not cultured for acid resistance and are therefore particularly vulnerable to high acid gastric environments, further hampering their effectiveness. One common method for getting around the vulnerability of vaccine cells is to administer them in conjunction with an antacid or other agent designed to protect from low pH.The technique improves survivability -- but at a cost. Without exposure to low pH, the salmonella vaccine bacteria lose valuable positional signals that help them colonize the intestine and successfully invade host tissue.

In the current study, heightened resistance to stomach acid was conferred to RASV strains through a special system using rhamnose-regulated arginine decarboxylase. The system was shown to dramatically increase survival of acid-sensitive S. Typhi in vitro at a pH of 2.5.

The researchers next sought to examine the effectiveness of RASV's containing the new acid resistance system in vivo, under the low pH conditions induced in the histamine mouse model. Results showed a 10-fold improvement in the ability of these modified strains to survive a gastric pH of 1.5 in the mouse stomach and to successfully reach the intestinal tract. The implication is that such modified vaccine strains will likewise survive similar low pH conditions in humans, dramatically improving their effectiveness.

The study findings suggest that the histamine mouse model may be a useful tool for evaluating not only RASV candidates but any orally administered microbial treatment, (for example pro-biotic bacteria). For microbes displaying acid sensitivity, the rhamnose-regulated arginine decarboxylase acid-resistance system can improve survivability under low pH and successful transit to the intestinal tract. Such improvement may elevate vaccine effectiveness while allowing a reduction in dose.


Story Source:

The above story is based on materials provided by Arizona State University. The original article was written by Richard Harth. Note: Materials may be edited for content and length.


Journal Reference:

  1. Karen E. Brenneman, Crystal Willingham, Jacquelyn A. Kilbourne, Roy Curtiss, Kenneth L. Roland. A Low Gastric pH Mouse Model to Evaluate Live Attenuated Bacterial Vaccines. PLOS ONE, February 2014 DOI: 10.1371/journal.pone.0087411

Cite This Page:

Arizona State University. "Reengineering salmonella-based vaccines to deliver protective immunity." ScienceDaily. ScienceDaily, 18 February 2014. <www.sciencedaily.com/releases/2014/02/140218114259.htm>.
Arizona State University. (2014, February 18). Reengineering salmonella-based vaccines to deliver protective immunity. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2014/02/140218114259.htm
Arizona State University. "Reengineering salmonella-based vaccines to deliver protective immunity." ScienceDaily. www.sciencedaily.com/releases/2014/02/140218114259.htm (accessed July 30, 2014).

Share This




More Plants & Animals News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Raw: Thousands Flocking to German Crop Circle

Raw: Thousands Flocking to German Crop Circle

AP (July 30, 2014) Thousands of people are trekking to a Bavarian farmer's field to check out a mysterious set of crop circles. (July 30) Video provided by AP
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Raw: Otters Enjoy Water Slides at Japan Zoo

Raw: Otters Enjoy Water Slides at Japan Zoo

AP (July 30, 2014) River otters were hitting the water slides to beat the summer heatwave on Wednesday at Ichikawa City's Zoological and Botanical Garden. (July 30) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins